Plain-English translation of NCT06912763 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
After radiation therapy for head and neck cancer, some patients develop scarring and swelling in the neck and jaw area that can make it hard to swallow or move their head. This trial is testing five different medications—Pravastatin, combined with Vitamin E, , Pirfenidone, and a control group receiving standard care—to see if any of them can reduce or reverse this scarring and swelling.
Scarring after radiation is a common problem that doesn't have a proven treatment yet. Researchers want to find a medication that can help prevent or improve this scarring so patients can recover better quality of life after cancer treatment.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take one of the five medications or receive standard care without a new medication for 12 months. During this time, you'll have clinic visits where doctors will examine your neck for scarring and swelling, you may have imaging tests like MRI or swallowing studies, and you'll fill out surveys about how you're feeling. At 12 months, doctors will measure whether your scarring and swelling have improved.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States